For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. If you need to see your provider, please contact us to see if a Video Visit is right for you. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Department of Anesthesiology

You are here

Optimal management of bleeding and transfusion in patients undergoing cardiac surgery.

TitleOptimal management of bleeding and transfusion in patients undergoing cardiac surgery.
Publication TypeJournal Article
Year of Publication1999
AuthorsDespotis GJ, Skubas NJ, Goodnough LT
JournalSemin Thorac Cardiovasc Surg
Date Published1999 Apr
KeywordsAlgorithms, Blood Coagulation Tests, Blood Transfusion, Cardiac Surgical Procedures, Deamino Arginine Vasopressin, Fibrinolysis, Hemostasis, Hemostasis, Surgical, Hemostatics, Humans, Point-of-Care Systems, Postoperative Hemorrhage, Risk Factors

Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are at increased risk for excessive perioperative blood loss requiring transfusion of blood products. Point-of-care evaluation of platelets, coagulation factors, and fibrinogen can enable physicians to rapidly assess bleeding abnormalities, facilitate the optimal administration of pharmacological and transfusion-based therapy, and also identify patients with surgical bleeding. The ability to reduce the unnecessary use of blood products in this setting has important implications for emerging issues in blood inventory and blood costs. The ability to decrease surgical time, along with exploration rates, has important consequences for health care costs in an increasingly managed health care environment.

Alternate JournalSemin. Thorac. Cardiovasc. Surg.
PubMed ID10378853